Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Radinov, Roumen
Alnylam Pharmaceuticals Inc.
(
T1430-01-03
)
Importance of Early-Stage Process Design Space Assessment for Lipid Nanoparticles (LNP) Technology Transfer
Roumen Radinov
Favorite
Radmall, Kyler
Aliri Bioanalysis
(
T1130-02-09
)
Considerations for Probe Selection for Oligonucleotide Hybridization LC/MS Workflows
Kyler Radmall
Favorite
Raha, Nancy
Pfizer Inc.
(
M1130-02-07
)
Embracing Singlicate Ligand Binding Biomarker Assays: A Case Study Comparing Duplicate vs Singlicate Analysis for the Determination of IL-6, IFN-gamma, and TNF-alpha in Human Sodium Heparin Plasma
Nancy Raha
Favorite
Rahman, Md Mofizur
Binghamton University
(
T1430-01-05
)
Rapid and Precise Detection of Mutations in Extracellular Vesicle DNA Using a Liposome-Based CRISPR-Cas12a System
Md Mofizur Rahman
Favorite
Rahman, Omar
Enable Injections
(
T1430-01-02
)
Insights from Drug Development Experts: Surveying Challenges and Outcomes for Large-Volume Subcutaneous Oncology Drugs
Omar Rahman
Favorite
Rainville, Paul D.
Waters Corporation
(
M1030-01-01
)
Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Paul D. Rainville
Favorite
Rajagopalan, Deepa
45 Management LLC
(
T1430-01-02
)
Insights from Drug Development Experts: Surveying Challenges and Outcomes for Large-Volume Subcutaneous Oncology Drugs
Deepa Rajagopalan
Favorite
Rathore, Anurag
IITD
(
T1230-01-05
)
Impact of Excipient Composition on the Stability of Trastuzumab Biosimilars
Anurag Rathore
Favorite
Ray, Arpita
Genentech, Inc.
(
M1030-02-07
)
Pharmacokinetic/Pharmacodynamic Insights into VSIG4 Degrading Antibodies
Arpita Ray
Favorite
Reddy, Gayathri Aparnasai
Duquesne University
(
T0930-01-04
)
Zinc-Associated Peptide Coacervates for Recombinant Protein Capture and Release
Gayathri Aparnasai Reddy
Favorite
Reed, Corey
Waters Corporation
(
M0930-01-05
)
Modernization of Compendial Size-Exclusion Chromatography Aggregation Analysis Methods in Compliance with Updates to USP General Chapter < 129 >
Corey Reed
Favorite
Refaat, Hesham
University of Iowa
(
T1230-01-05
)
Impact of Excipient Composition on the Stability of Trastuzumab Biosimilars
Hesham Refaat
Favorite
Reineke, Joshua
South Dakota State University
(
M0930-01-02
)
Exploring the Impact of Iron Availability on Morphology and Antibiotic Resistance in
Mycobacterium
Species
Joshua Reineke
Favorite
Ren, Steven
WuXi Biologics US
(
T1230-01-03
)
Break Loose Force and Glide Force Evaluation of Various Container Closure System Combination for Empty Syringe
Steven Ren
Favorite
Reynolds, Anh
Bristol-Myers Squibb Company
(
M1030-02-08
)
Simplifying Cellular Immunogenicity Monitoring for Novel Therapeutics through a sMHC-1 Immunopeptidomics Approach
Anh Reynolds
Favorite
Rizvi, Syed
Oregon State University
(
M1330-01-05
)
Mitigation of Doxorubicin-Induced Cardiotoxicity and Chemosensitization Using Combination Phytochemicals in Polymeric Micelles
Syed Rizvi
Favorite
(
T0930-01-02
)
Investigating the Effects of Multi-Drug-Loaded Nanospheres in Enhancing Antitumor Efficacy and Augmenting Immune Response Against Metastatic Melanoma
Syed Rizvi
Favorite
Roadcap, Brad
Merck & Co., Inc.
(
T1130-02-06
)
Using Tasso-M20 Microsampling Device to Support a Clinical PK Study
Brad Roadcap
Favorite
Robbins, David
Eurofins Viracor BioPharma Services
(
M1230-02-08
)
Comprehensive AAV-Based Vector Shedding Assessment by PCR: A Case Study with Whole Blood, Serum, Semen, Urine, and Buccal Swab
David Robbins
Favorite
Roberge, Martin
Cerba Research
(
T1130-02-07
)
Mitigation of the Presence of Crosstalk in an ADA Bridging Assay Using the MSD Platform for the Detection of Antibodies against an Antibody-Drug Conjugate
Martin Roberge
Favorite
Ross, Alexander
Qatch Technologies
(
M1030-01-03
)
High-Throughput Viscometry with Injectability Screening of High Concentration Protein Formulations by Multiplexed Microfluidic Quartz Resonators
Alexander Ross
Favorite
Rowe, Josh
AbbVie Inc.
(
M0930-02-08
)
Fit for Purpose Qualified Assays to Assess Exploratory Biomarkers in Human Aqueous Humor to Unveil Target Engagement and Pharmacological Activity in Complement Factor C5 Inhibition Clinical Studies
Josh Rowe
Favorite
